Skip to main content

Day: October 30, 2024

Carriage Services Announces Strong Third Quarter 2024 Results and Increases Full-Year 2024 Outlook

 Conference call on Thursday, October 31, 2024 at 9:30 a.m. central time HOUSTON, Oct. 30, 2024 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) today announced its financial results for the third quarter ended September 30, 2024. Company Highlights:A 27.1% increase in consolidated cemetery preneed sales, and an increase of 3.1% in consolidated funeral average revenue per contract, helped drive revenue of $100.7 million, representing growth of 11.3% over the prior year quarter; GAAP net income growth of 112.4%, and Adjusted Consolidated EBITDA growth of 26.7%, over the prior year quarter; GAAP diluted EPS of $0.63 and adjusted diluted EPS of $0.64, compared to $0.30 and $0.33 in the prior year quarter, a growth of 110% and 94%, respectively; Leverage ratio lowered to 4.3x from 5.3x at the same period last year, as the Company...

Continue reading

Allied Announces Third-Quarter Results

TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX: “AP.UN”) today announced results for the three months ended September 30, 2024. “Our occupied and leased area remained steady for the second consecutive quarter, and our urban workspace portfolio continued to outperform the market,” said Cecilia Williams, President & CEO. “With demand rising in Canada’s major cities, we expect our leasing activity to accelerate over the remainder of the year and into 2025.” Operations Allied’s portfolio is comprised of three urban workspace formats. Allied Heritage is a format created through the adaptive re-use of light industrial structures for office use above grade and retail use at grade. The buildings are inherently distinctive, clustered in the urban core...

Continue reading

Superior Energy Services Announces Third Quarter 2024 Results and Conference Call

HOUSTON, Oct. 30, 2024 (GLOBE NEWSWIRE) — Superior Energy Services, Inc. (the “Company”) filed its Form 10-Q for the period ended September 30, 2024. In accordance with the Company’s Shareholders Agreement, it will host a conference call with shareholders on November 1, 2024. For the third quarter of 2024, the Company reported net income from continuing operations of $21.9 million, or $1.09 per diluted share, with revenue of $197.3 million. This compares to net income from continuing operations of $29.5 million or $1.46 per diluted share, with revenue of $201.1 million, for the second quarter of 2024. The Company’s Adjusted EBITDA (a non-GAAP measure defined on page 4) was $57.8 million compared to $60.0 million for the second quarter of 2024. Refer to pages 11 and 12 for a reconciliation of Adjusted EBITDA to GAAP results. Third...

Continue reading

Pilgrim’s Pride Reports Third Quarter 2024 Results with $4.6 Billion in Net Sales and Operating Income of $508.4 Million

GREELEY, Colo., Oct. 30, 2024 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC), one of the world’s largest poultry producers, reports its third quarter 2024 financial results. Third Quarter HighlightsNet Sales of $4.6 billion. Consolidated GAAP operating income margin of 11.1%. GAAP Net Income of $350.0 million and GAAP EPS of $1.47. Adjusted Net Income of $387.0 million or Adjusted EPS of $1.63. Adjusted EBITDA of $660.4 million, or a 14.4% margin. Our U.S. Fresh portfolio continued to improve through progress in operational excellence, strong demand, and enhanced mix. Overall chicken demand was strong given competitive pricing and value delivered to the consumer, with our Key Customers expanding faster than category averages in the Case Ready and Small Bird segments. The Commodity segment improved given continued...

Continue reading

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

PRINCETON, N.J., Oct. 30, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2024 financial results on Friday, November 8, 2024, prior to the market open. Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, and Chris Mutz, Head of Rare Disease, will host a conference call to discuss the results as follows:Date Friday, November 8, 2024  Time 8:00 a.m. ET  Toll free (U.S.) 800-445-7795  Conference ID 4757982  Webcast (live and replay) www.anipharmaceuticals.com, under the “Investors” section       A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for two weeks...

Continue reading

Altair Announces Third Quarter 2024 Financial Results

TROY, Mich., Oct. 30, 2024 (GLOBE NEWSWIRE) — Altair (Nasdaq: ALTR), today released its financial results for the third quarter and nine months ended September 30, 2024. Immediately prior to the dissemination of this press release, Altair issued a press release announcing that it has entered into a merger agreement with a subsidiary of Siemens pursuant to which Altair will be acquired and stockholders of Altair will receive cash merger consideration as more fully described in that press release. Third Quarter 2024 Financial ResultsSoftware revenue was $138.7 million compared to $119.1 million for the third quarter of 2023, an increase of 16.5% in reported currency and 16.2% in constant currency Total revenue was $151.5 million compared to $134.0 million for the third quarter of 2023, an increase of 13.0% in reported currency...

Continue reading

Altair Signs Definitive Agreement with Siemens to be Acquired for $10.6 Billion

Altair Stockholders to Receive $113 Per Share in Cash TROY, Mich., Oct. 30, 2024 (GLOBE NEWSWIRE) — Altair (Nasdaq: ALTR), a global leader in computational intelligence, today announced that it has entered into a definitive agreement to be acquired by Siemens, a leading technology company focused on industry, infrastructure, mobility, and healthcare. Altair stockholders will receive $113.00 per share in cash, representing an equity value of approximately $10.6 billion.  The $113.00 per share cash consideration represents a 19% premium to the closing price of Altair common stock on October 21, 2024, the last trading day prior to media speculation regarding a potential transaction, and a 13% premium to Altair’s unaffected all-time high closing price. “This acquisition represents the culmination of nearly 40 years in which Altair...

Continue reading

Rush Street Interactive Announces Third Quarter 2024 Results and Raises Full Year Guidance

– Third Quarter Revenue of $232 Million, up 37% Year-over-Year –– Third Quarter Net Income of $3.2 Million –– Strong Momentum Continues with Third Quarter Adjusted EBITDA of $23 Million –– Raising Full Year 2024 Adjusted EBITDA Guidance 24% at the Midpoint with a Revised Range of Between $82 and $86 Million –– Announces Share Repurchase Authorization of $50 Million – CHICAGO, Oct. 30, 2024 (GLOBE NEWSWIRE) — Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States and the rest of the Americas, today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 and Recent HighlightsRevenue was $232.1 million during the third quarter of 2024, an increase of 37%, compared...

Continue reading

Cellectis to Report Third Quarter 2024 Financial Results on November 4, 2024

NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) —  Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the third quarter 2024 ending September 30, 2024 on Monday, November 4, 2024 after the close of the US market. The publication will be followed by an investor conference call and webcast on Tuesday, November 5, 2024 at 8:00 AM ET / 2:00 PM CET. The call will include the Company’s third quarter results and an update on business activities. Details for the call are as follows: Dial in information: Domestic: +1-800-225-9448 International: +1-203-518-9708 Conference ID: CLLSQ3 Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1688144&tp_key=affca25222 About...

Continue reading

VitalHub Announces Acquisition of Strata Health

TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) — VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has acquired (the “Acquisition”) Strata Health Solutions Inc. (“Strata Health”), a leading provider of patient flow solutions internationally. Based in Canada, Strata Health designs, builds, and deploys software that improves access and navigation to care. Strata Health has over 80 health system partners and works with over 500 hospitals to provide over 800,000 patient transitions annually. The company serves customers in Canada, the UK, the US, and New Zealand with offices internationally. Strata Health extends VitalHub’s solution set into the electronic referral market, a large and growing market opportunity internationally. Poor transitions of care result in fragmented delivery, unsatisfactory...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.